Mumio helped a brain tumor drug work better in lab cells
Original title: Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a lab dish, not in people.
The short version
A natural substance called Mumio helped kill brain tumor cells in a lab dish.
What was studied. Researchers tested an extract of Mumio, also called Shilajit, on glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells. They used two cell lines, U87 and LN-18. One responds to the drug temozolomide, and the other resists it.
What they found. Mumio killed more tumor cells as the dose went up and the time went on. It stressed the cells, harmed their energy parts, and set off cell death. Mumio also made temozolomide kill more cells, including in the resistant line.
What this means, and what it doesn't
What it could mean: Nothing changes for patients today. It is an early hint that Mumio might help chemo work in tumors that resist temozolomide. That idea still has to be tested in animals, and then in people.
What it doesn't mean: This does not mean Mumio treats brain tumors in people. The work was done on cells in a dish. It was not tested in animals or in patients. It is not a cure, and it is not a treatment you can ask for. It also does not mean Shilajit supplements help brain tumors.
Source: PubMed, August 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.